We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microarray-Based Diagnostic Will Detect Sepsis-Triggering Pathogens

By HospiMedica staff writers
Posted on 09 Oct 2007
A comprehensive DNA microarray-based diagnostic test will be able to detect both bacterial and fungal sepsis-triggering pathogens.

Approximately 18 million cases of sepsis occur worldwide per year. More...
The mortality rate for sepsis is 28-50%, and the associated costs are estimated at US$20 billion. Quick and precise diagnosis of sepsis is crucial to the success of a course of a therapy.

Current diagnostic processes rely on time-consuming cultivation of pathogenic microbes. The DNA microarray-based diagnostic under development will enable the immediate detection of organism-specific nucleic acid sequences, reduce the time between sample collection and diagnosis, and thus lead to a reduction in mortality rates.

GATC Biotech (Constance, Germany), a DNA sequencing service provider, has entered into a collaboration agreement with the Fraunhofer Institute in Germany, and the National University of Pusan (Pusan, Republic of Korea) and biotech company Gene In Corp., Ltd, (South Korea). GATC Biotech is the coordinating partner of the collaboration, which aims to develop the diagnostic test.

Peter Pohl, CEO of GATC Biotech, commented, "We are delighted to be taking part in this collaboration. With nearly two decades of experience in genetic analysis, GATC Biotech is ideally positioned to contribute to research projects relating to human health. The clinical diagnostics field is still dominated by classic microbial procedures, involving the time-consuming cultivation of pathogenic germs. The successful development of a DNA-based diagnostic will reduce the time between sample collection and diagnosis, and will represent a huge step towards increasing survival rates for patients.”

The project is one of several that connect GATC Biotech's DNA analysis expertise with demanding medical conditions. Additional projects that GATC Biotech is contributing to include CONSERT (Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis for Gene Therapy of Inherited Diseases), XENOME (detection of retroviral elements in the porcine genome), and EURESFUN (integrated post-genomic approaches for the understanding, detection, and prevention of antifungal drug resistance in fungal pathogens).

GATC Biotech is a provider of DNA sequencing services and bioinformatics software for industry and academia worldwide. GATC Biotech offers complete sequencing systems, from sample prep to high-throughput genome sequencing and bioinformatics.


Related Links:
GATC Biotech
National University of Pusan

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Aliya EX Generator for surgical ablation of soft tissue (Photo courtesy of Galvanize Therapeutics)

Next-Generation PEF System Delivers Larger Ablation Zones for Soft-Tissue Procedures

Interventional teams often need soft-tissue ablation options that can be performed percutaneously or endoscopically while minimizing collateral injury and preserving procedural workflow.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.